• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Sobrera Pharma

Monday, June 03, 2024
CP
CNS/Neurological
Sobrera Pharma is a Swedish pharmaceutical company and a leader in research and development in the area of addiction and related diseases. The Companies main asset is in clinical phase II and has shown very promising clinical results for the treatment of patients with Alcohol Use Disorder (AUD) / alcohol addiction. Today more than 2oo million people suffer from AUD. Of people who drink heavily over many years 20% - 25% will develop liver cirrhosis. Research has shown that people with alcohol addiction have a greater risk to develop heart disease, depression and cancers. The medical community has in recent years begun to place more focus on the risks associated with overconsumption of alcohol and the medical need. Sobrera focus their research on correcting the dopamine imbalance in the brain that creates the need for alcohol. The focus for the product in development is to reduce alcohol consumption, cravings and to improve Quality of Life for people with moderate/severe AUD.
Sobrera Pharma
Company Website: http://www.sobrera.com
Lead Product in Development: SO-001
Number Of Unlicensed Products (For Which You Are Seeking Partners): 1

Company HQ City

Göteborg

Company HQ State

Västra Götaland

Company HQ Country

Sweden

CEO/Top Company Official

Ann-Charlotte Rosendahl

Development Phase of Primary Product

Phase II
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS